Clinical Trial of CD19 and CD22 CAR Sequential Therapy Versus Single CD19 CAR Bridging to HSCT for r/r B-ALL Patients

NCT06343090 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

353

Enrollment

OTHER

Sponsor class

Conditions

B-cell Acute Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia, in Relapse
Refractory Acute Lymphoid Leukemia

Interventions

DRUG: CD19 CAR T-cell
DRUG: CD22 CAR T cells
PROCEDURE: hematopoietic stem-cell transplantation

Sponsor

Beijing GoBroad Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]